Osmotic dosage forms comprising deutetrabenazine and methods of use thereof

TW202633624APending Publication Date: 2026-08-16AUSPEX PHARMA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114151322
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-06-26
Filing Date
2021-06-10
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001073315_001
    Figure TWG2TA001073315_001
  • Figure TWG2TA001073315_002
    Figure TWG2TA001073315_002
  • Figure TWG2TA001073315_003
    Figure TWG2TA001073315_003
Patent Text Reader

Abstract

Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
Need to check novelty before this filing date? Find Prior Art